Cambridge Healthtech Institute's Fifth Annual

Antibody-Drug Conjugates

( 抗体药物复合物 )

Engineering for Clinical Success

2018年1月9日 - 10日


Cambridge Healthtech Institute's Antibody-Drug Conjugates conference reveals the engineering that has brought about today's ADC revolution, and examines how to design safe and effective therapeutics. Exploring options for selecting new targets and ensuring potency will be discussed, along with strategies for advancing ADCs to the clinic. A special focus on fighting cancer will be highlighted including tumor penetration. Analyzing ADCs to explore conjugation, stability, and payloads and will also be addressed in this leading ADC event.

We invite presentation proposals on the following preliminary topics:

  • Case studies
  • Next-generation ADCs
  • Pre-Clinical & clinical data
  • Target selection - new targets
  • Linker-drug technologies
  • Linker engineering
  • Conjugation chemistries
  • Novel payloads
  • Delivery
  • Tumor penetration
  • Drug-to-antibody ratio (DAR)
  • Potency
  • Specificity/Stability
  • Toxicity
  • Bioanalytical challenges
  • Mode of action
  • Novel targets
  • Assay development

* 活动内容有可能不事先告知作更动及调整。